Omnibus Appropriations Bill Increases Research Funding
House and Senate appropriations committees released an FY 2014 omnibus appropriations bill on January 13 that would fund the federal government through September and restores some of the funding lost to the across-the-board cuts from sequestration. The bill includes all 12 FY 2014 spending bills.
May 9, 2013 - ASM Sends Letter Regarding CDC Advanced Molecular Detection (AMD) Infectious Disease Initiative
The ASM sent a letter to all members of the House and Senate Appropriations Subcommittees on Labor, Health and Human Services, Education, and Related Agencies regarding the CDC's Advanced Molecular Detection (AMD) and Response to Infectious Disease Outbreaks initiative.
ASM Congressional Briefing - The Perpetual Challenge of Infectious Diseases: New and Emerging and Antimicrobial Resistance
The ASM held a Congressional Briefing on Tuesday, April 30 on The Perpetual Challenge of Infectious Diseases: New and Emerging and Antimicrobial Resistance
On April 10, the President released the Administration’s fiscal year (FY) 2014 budget request to Congress. The ASM has prepared an overview of federal agency research and development and public health funding levels.
ASM sent comments to the Office of Science and Technology Policy regarding the February 22, 2013 United States Government Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern
The ASM sent comments to the NIH's Office of Biotechnology Activities regarding changes to the NIH Guidelines for Research Involving Recombinant DNA Molecules.
The Office of Science and Technology Policy (OSTP) released for public review and comment the proposed policy for institutional oversight of life sciences dual use research of concern.
Dr. Timothy Donohue, President Elect of ASM, spoke about microbiology and ASM during the public comment session of the NIGMS Council meeting on January 24, 2014.
Laboratory Practices Committee Prepares Cyclospora Guideline -
The Public and Scientific Affairs Board (PSAB) Committee on Laboratory Practices prepared A Practical Guidance Document to the Detection of Cyclospora to aid laboratory personnel in their identification of this organism, since routine ova and parasite examination often fails to detect it. The document was drafted by Marc Roger Couturier and Susan Sharp, and reviewed by the Committees on Laboratory Practices and Public Health.
Sentinel Level Clinical Laboratory Protocols For Suspected Biological Threat Agents And Emerging Infectious Diseases
The ASM, in collaboration with CDC and APHL, has updated the Sentinel Level Clinical Laboratory Guidelines for Suspected Agents of Bioterrorism and Emerging Infectious Diseases.